88IV - PR Newswire Asia's news - Medical/Pharmaceuticals


CONCEPT MEDICAL ANNOUNCES ENROLLMENT OF FIRST PATIENT IN "MAGICAL-ISR" IDE STUDY IN THE US TAMPA, Fla. , April 20, 2024 /PRNewswire/ -- Concept Medical , a pioneer in innovative drug delivery technologies, proudly announces the commencement of its groundbreaking IDE clinical study, "MAGICAL-ISR" ... 2024-04-20T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Inaugural 'Korea Medical Innovation Research Forum' regular seminar, a success To be registered as an official research organization by the National Assembly Secretariat... Expected to become Korea's leading medical think tank Planning to initiate global multinational clinical ... 2024-04-19T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
Concord Medical Files 2023 Annual Report on Form 20-F BEIJING , April 19, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer ... 2024-04-19T Banking/Financial Service Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024 GAITHERSBURG, Md. , April 19, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, ... 2024-04-19T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
GenFleet Therapeutics Announces FDA's Clinical Trial Approval for GFH925 (KRAS G12C Inhibitor) Monotherapy in Phase III Registrational Study Treating Metastatic Colorectal Cancer SHANGHAI , April 19, 2024 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration ... 2024-04-19T Health Care/Hospital Medical/Pharmaceuticals
Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization SEOUL, South Korea , April 19, 2024 /PRNewswire/ -- South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com ) announced on April 15 that it would carry ... 2024-04-19T Biotechnology Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals
Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization SEOUL, South Korea , April 19, 2024 /PRNewswire/ -- South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com ) announced on April 15 that it would carry ... 2024-04-19T Biotechnology Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals
Cognivia Secures Strategic 15.5M Funding to Empower Drug Development with AI-ML Solutions Using patient personality traits to pioneer a new era in clinical research. ... 2024-04-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine GAITHERSBURG, Md. , April 18, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, ... 2024-04-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
European Wellness Leads Pioneering Down Syndrome Research at Heidelberg University HEIDELBERG, Germany , April 18, 2024 /PRNewswire/ -- The European Wellness Biomedical Group (EWBG), in collaboration with the European Wellness Academy (EWA), the Baden Research Lab, and Heidelberg ... 2024-04-18T Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Medical/Pharmaceuticals